205 related articles for article (PubMed ID: 24743780)
1. Analysis of molecular cytogenetic alteration in rhabdomyosarcoma by array comparative genomic hybridization.
Liu C; Li D; Jiang J; Hu J; Zhang W; Chen Y; Cui X; Qi Y; Zou H; Zhang W; Li F
PLoS One; 2014; 9(4):e94924. PubMed ID: 24743780
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal and genetic imbalances in Chinese patients with rhabdomyosarcoma detected by high-resolution array comparative genomic hybridization.
Liu C; Li D; Hu J; Jiang J; Zhang W; Chen Y; Cui X; Qi Y; Zou H; Zhang W; Li F
Int J Clin Exp Pathol; 2014; 7(2):690-8. PubMed ID: 24551291
[TBL] [Abstract][Full Text] [Related]
3. Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma.
Pandita A; Zielenska M; Thorner P; Bayani J; Godbout R; Greenberg M; Squire JA
Neoplasia; 1999 Aug; 1(3):262-75. PubMed ID: 10935481
[TBL] [Abstract][Full Text] [Related]
4. [Comparative genomic hybridization: the profile of chromosomal imbalances in rhabdomyosarcoma].
Li QX; Liu CX; Chun CP; Qi Y; Chang B; Nong WX; Yao ES; Li HA; Li F
Zhonghua Bing Li Xue Za Zhi; 2008 Aug; 37(8):536-41. PubMed ID: 19094465
[TBL] [Abstract][Full Text] [Related]
5. Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development.
Missiaglia E; Selfe J; Hamdi M; Williamson D; Schaaf G; Fang C; Koster J; Summersgill B; Messahel B; Versteeg R; Pritchard-Jones K; Kool M; Shipley J
Genes Chromosomes Cancer; 2009 Jun; 48(6):455-67. PubMed ID: 19235922
[TBL] [Abstract][Full Text] [Related]
6. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
7. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization.
Weber-Hall S; Anderson J; McManus A; Abe S; Nojima T; Pinkerton R; Pritchard-Jones K; Shipley J
Cancer Res; 1996 Jul; 56(14):3220-4. PubMed ID: 8764111
[TBL] [Abstract][Full Text] [Related]
8. Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.
Barr FG; Duan F; Smith LM; Gustafson D; Pitts M; Hammond S; Gastier-Foster JM
Genes Chromosomes Cancer; 2009 Aug; 48(8):661-72. PubMed ID: 19422036
[TBL] [Abstract][Full Text] [Related]
9. Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma.
Ragazzini P; Gamberi G; Pazzaglia L; Serra M; Magagnoli G; Ponticelli F; Ferrari C; Ghinelli C; Alberghini M; Bertoni F; Picci P; Benassi MS
Histol Histopathol; 2004 Apr; 19(2):401-11. PubMed ID: 15024701
[TBL] [Abstract][Full Text] [Related]
10. Aberrant CDK4 amplification in refractory rhabdomyosarcoma as identified by genomic profiling.
Park S; Lee J; Do IG; Jang J; Rho K; Ahn S; Maruja L; Kim SJ; Kim KM; Mao M; Oh E; Kim YJ; Kim J; Choi YL
Sci Rep; 2014 Jan; 4():3623. PubMed ID: 24406431
[TBL] [Abstract][Full Text] [Related]
11. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes.
Bridge JA; Liu J; Qualman SJ; Suijkerbuijk R; Wenger G; Zhang J; Wan X; Baker KS; Sorensen P; Barr FG
Genes Chromosomes Cancer; 2002 Mar; 33(3):310-21. PubMed ID: 11807989
[TBL] [Abstract][Full Text] [Related]
12. Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study.
Bridge JA; Liu J; Weibolt V; Baker KS; Perry D; Kruger R; Qualman S; Barr F; Sorensen P; Triche T; Suijkerbuijk R
Genes Chromosomes Cancer; 2000 Apr; 27(4):337-44. PubMed ID: 10719362
[TBL] [Abstract][Full Text] [Related]
13. Genetic and molecular alterations in rhabdomyosarcoma: mRNA overexpression of MCL1 and MAP2K4 genes.
Pazzaglia L; Chiechi A; Conti A; Gamberi G; Magagnoli G; Novello C; Morandi L; Picci P; Mercuri M; Benassi MS
Histol Histopathol; 2009 Jan; 24(1):61-7. PubMed ID: 19012245
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal imbalances in pleomorphic rhabdomyosarcomas and identification of the alveolar rhabdomyosarcoma-associated PAX3-FOXO1A fusion gene in one case.
Gordon A; McManus A; Anderson J; Fisher C; Abe S; Nojima T; Pritchard-Jones K; Shipley J
Cancer Genet Cytogenet; 2003 Jan; 140(1):73-7. PubMed ID: 12550764
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic and molecular findings related to rhabdomyosarcoma. An analysis of seven cases.
Gil-Benso R; López-Ginés C; Carda C; López-Guerrero JA; Ferrer J; Pellín-Pérez A; Llombart-Bosch A
Cancer Genet Cytogenet; 2003 Jul; 144(2):125-33. PubMed ID: 12850375
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of GEFT, a Rho family guanine nucleotide exchange factor, predicts poor prognosis in patients with rhabdomyosarcoma.
Sun C; Liu C; Li S; Li H; Wang Y; Xie Y; Li B; Cui X; Chen Y; Zhang W; Li F
Int J Clin Exp Pathol; 2014; 7(4):1606-15. PubMed ID: 24817957
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic studies in subgroups of rhabdomyosarcoma.
Whang-Peng J; Knutsen T; Theil K; Horowitz ME; Triche T
Genes Chromosomes Cancer; 1992 Nov; 5(4):299-310. PubMed ID: 1283318
[TBL] [Abstract][Full Text] [Related]
18. A study of alveolar rhabdomyosarcoma copy number alterations by single nucleotide polymorphism analysis.
Lynn M; Shah N; Conroy J; Ennis S; Morris T; Betts D; O'Sullivan M
Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):213-21. PubMed ID: 24614150
[TBL] [Abstract][Full Text] [Related]
19. CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma.
Olanich ME; Sun W; Hewitt SM; Abdullaev Z; Pack SD; Barr FG
Clin Cancer Res; 2015 Nov; 21(21):4947-59. PubMed ID: 25810375
[TBL] [Abstract][Full Text] [Related]
20. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
Lassmann S; Weis R; Makowiec F; Roth J; Danciu M; Hopt U; Werner M
J Mol Med (Berl); 2007 Mar; 85(3):293-304. PubMed ID: 17143621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]